In our paper, we evaluate the impact of a mobile assistive technology (MAT) that may increase the self-sufficiency and autarky of end users and informal caregivers in aspects of costs of care and quality of life. The focused mobile assistive system aims at reducing the patient's probability to need inpatient care. We use a Markov model that encompasses stage depended costs for dementia. Stages represent care arrangements that may be directly influenced by the mobile device and its corresponding service structure. A random virtual sample of about 300.000 people aged 65 and more was included. A continuous incidence of 3.2 % is assumed. We compute the cumulative cost-effectiveness after eight years which is a proxy for the maximum period of living with dementia and predict a surplus of 1,892 additional life years gained in outpatient setting using the mobile technology advice. Moreover, there is a cumulative cost advantage of about € 69 million. The economic impact of an assistive technology presumes a high level of acceptance but the research has to go on to elaborate different countervailing effects.
Introduction
Considering the challenge of age-related diseases with chronic characteristics like dementia, there is an increased need of organized care for informal caregivers. Thus, the role and number of professional care services and longterm care institutions will be even more relevant. Particularly, geriatric diseases like dementia are an increasing challenge for families because in most industrialized countries family members have cared for the elderly without any professional assistance [1] . Relating to literature two strands can be mentioned. A first line of literature stresses the potential interaction between formal and informal caregiving which relates to the scope and effectiveness of organisational assistance for outpatient caregiving [2] . Papers like Van Houten and Norton (2004) highlight the role of reimbursement schemes for doing informal care as well as the role an organised cost payers should have. The second line of papers discusses forms of technological and global economic aspects ambient assisted living has for home-based nursing as well as sheltered homes without respect to explicit economic evaluation of long-term care effects [3] . Hence, for promoting business models in ambient assisted living it becomes more relevant to stress aspects of product and process innovation by introducing assistive technologies. In our paper, we evaluate the impact of a mobile assistive technology (MAT) that may increase the selfsufficiency and autarky of end users and informal caregivers in aspects of costs of care and quality of life. For sharpening the perspective of our economic model we use the consequences of assistive care that are involved in new ways of organising outpatient care for people suffering from dementia.
Methods

Research agenda
Before discussing the economic model we describe the idea of an assistive system which helps people suffering from dementia to foster needs for autonomy and autarky. Dementia itself is a broad term describing a decline in intellectual functioning that result in cognitive impairments as well as in higher risks for falls or elopement. As dementia is in timeline of increasing dependency the role of the interplay of different forms of care is relevant [4] . Hence, an assistive care system that combines needs for safety and communication as well as tracking and observation could help caregivers as well as cared-people to remain independent for longer period of time. An assistive technology in the sense described above tries to compensate disabilities or enhances strategies for empowering cared-persons living in their own environment. For evaluating the impact of the assistive health care system we stress methods of economic evaluation. We want to proof the hypotheses that an introduction of a MAT would enable formal and informal caregivers to organise care and cure for people suffering from dementia more effectively. Especially, the MAT in our model is a mean that allows caregivers to delegate some care giving activities to the mobile system for instance tracking, activity monitoring as well as fall detection. Hence, using the assistive system would have an impact upon the caregiver´s marginal productivity for care and cure.
Theoretical background
To compute the economic cost-effectiveness we refer to a cost-effectiveness-model that employs a head-to-head design without addressing a patient-related outcome. The theory of economic evaluation encompasses two main strategies: measurement and assessment [5] . The first one tries to find out an appropriate way to highlight the economic cost center that reflects an average patient's career very well. The second one aims at the decision process a third party has to go through. The economic evaluation should help the third party to rationalize its decision. In order to gain an economic evaluation tool we compare costs and outcome. As the relating research project "Barrier free Health Assistance" does only aim at a laboratory prototype we use assumptions to elaborate the effectiveness of the assistive care system. Hence, the outcome depicts the probability to need inpatient care which does not reflect any patients' utilities at all. In consequence we refer to cost-effectiveness-analysis without considering any patients' related outcomes. Moreover, we employ modeling techniques to overcome the missing empirical data which are a result by the research project. In other words, we predict the costs of the MAT for a long-term period in comparison to a virtual cohort not using the MAT. As we cannot refer to detailed empiric effectiveness we employ a Markov model [5] . In a good strategy for economic evaluation all relevant parameters should be included to prepare an appropriate instrument for value for money. Since rarely all information come from the same source it is appropriate to use modeling techniques to get a theoretically based framework for further research. A Markov model can be used given expected costs and outcomes are an adequate approximation of the unknown value for money.
Baselines of the model
We refer to a standard patient career for people suffering from dementia. In our first stage these persons are included after getting the diagnosis but firstly not getting any kind of organized care. Organized care in the paper means a kind of team production where informal and formal care acts simultaneously [6] . We assume this kind of team production is the best approximation for depicting the team production effects of formal and informal care for people suffering with dementia. This idea resembles the care categories used by Rothgang et. al. (2011) and therefore we can outline five different stages [7] :
Diagnosed Dementia but no care
• Stage 2: Outpatient Care with higher level for informal care
• Stage 3: Outpatient Care with higher level for formal care
Inpatient Care, patients do not reverse to outpatient care
• Stage 5: Death
The structure of model is depicted in figure 1.
Figure 1: Markov-Model
Referring to a Markov-Model we set stages 4 and 5 as absorbing stages. They reflect the basic hypotheses that the MAT should enable people to stay longer in different forms of outpatient care.
Data set
For the first computation we refer to published data regarding the cost weights and transmission probabilities for the stages involved. The last one follows the research done by Kiencke et al. (2011) [8] .
Because of the desktop research we cannot differentiate the two outpatient stages and therefore both stages are combined. For the cost weights we also refer to Kiencke et. al. as well as to Häcker et al. (2007) [9] .
• Costs Stage 1: 2,635 € p.a.
• The increasing costs per stage are the result of a higher level of formal caregiving as well as the higher impact of care and cure technologies that are involved. The transmission probability has to be adjusted from a probability per quarter to a one-year transmission probability [8] . Kiencke et al. use a probability for mid-year term and therefore we have convert this probability back to an one-yearprobability.
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• 30 percent for patients located in an outpatient rangement.
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Conclusions
The economic impact of an assistive technology can be discussed within a health case dementia. We focus on care arrangements that help to different costs of formal and informal care to hig light the impact of a MAT the declared assumptions patient`s career being more effective by prolonging the outpatient period. ing effects. The benefit of following from the shorter inpatient care period weigh the costs of higher in consequence of cially long-term effects caused by the burden of care for the informal caregiver health as well as the employability need to be considered in further research. the distribution function of the effectiveness and the costs more precisely in the future. endusers' willingness benefit basket shall be focused in This paper is a result of the project "Barrier free Health Assistance" supported by cation and Re 01EX1014A.
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